Search results for " transplantation."

showing 10 items of 1389 documents

Uterus transplantation from a deceased donor

2018

medicine.medical_specialtyDeceased donorbusiness.industryUterusGeneral Medicine030230 surgeryTissue DonorsSurgery03 medical and health sciences0302 clinical medicineInfertilityUterus transplantationLiving DonorsmedicineHumansFemale030212 general & internal medicinebusinessThe Lancet
researchProduct

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN CLL: FIRST RESULTS OF AN EBMT RANDOMIZED TRIAL COMPARING AUTOTRANSPLANT VERSUS WAIT …

2010

Abstract Abstract 877 This phase-III randomized EBMT-intergroup trial studied the impact of a consolidating autoHSCT vs no consolidation for patients with CLL in Binet stage A progressive, B or C , in CR, nodular PR or VGPR after first or second line therapy. The primary objective was to show that autoHSCT increased the 5-year progression-free survival (PFS) by 30%. Although it had been calculated that 270 patients were to be randomized, the study was terminated by the steering committee in July 2007 due to poor accrual. Here we present a first analysis based on 69% of expected follow-up forms. Results: Between November 2001 and July 2007, 223 patients were enrolled (SFGM-TC/FCLLG n=98, MRC…

medicine.medical_specialtyDisease statusRandomizationbusiness.industrymedicine.medical_treatmentIncidence (epidemiology)ImmunologyCell BiologyHematologyHematopoietic stem cell transplantationBiochemistrySurgerylaw.inventionRandomized controlled triallawInternal medicinemedicineIn patientProgression-free survivalStage (cooking)business
researchProduct

Biliary complications after liver transplantation: current perspectives and future strategies

2021

Importance: Liver transplantation (LT) is a life-saving therapy for patients with end-stage liver disease and with acute liver failure, and it is associated with excellent outcomes and survival rates at 1 and 5 years. The incidence of biliary complications (BCs) after LT is reported to range from 5% to 20%, most of them occurring in the first three months, although they can occur also several years after transplantation.Objective: The aim of this review is to summarize the available evidences on pathophysiology, risk factors, diagnosis and therapeutic management of BCs after LT.Evidence Review: a literature review was performed of papers on this topic focusing on risk factors, classificatio…

medicine.medical_specialtyEndoscopic retrograde cholangiopancreatographyPercutaneousmedicine.diagnostic_testBile ductbusiness.industryLiver transplantation (LT) biliary tract diseases cholangiography cholangiopancreatography endoscopic retrograde reviewmedicine.medical_treatment030230 surgeryLiver transplantationmedicine.diseaseSurgeryTransplantation03 medical and health sciencesLiver disease0302 clinical medicinemedicine.anatomical_structureCholangiographymedicineEtiology030211 gastroenterology & hepatologybusinessHepatobiliary Surgery and Nutrition
researchProduct

Cardiac reinnervation influences exercise training outcomes in heart transplant patients.

2019

medicine.medical_specialtyEpidemiologybusiness.industryMEDLINEHeartText miningmedicine.anatomical_structurePhysical therapyMedicineHeart TransplantationHumansTransplant patientCardiology and Cardiovascular MedicinebusinessExerciseReinnervationEuropean journal of preventive cardiology
researchProduct

Influence of different CyA formulations and calcium channel blocker phenyhidine regimens on intracellular (erythrocyte) calcium levels after kidney t…

1997

medicine.medical_specialtyErythrocytesmedicine.drug_classPrednisolonechemistry.chemical_elementAdministration OralCalcium channel blockerCalciumInternal medicineAzathioprinemedicineHumansDrug InteractionsKidney transplantationDosage FormsTransplantationKidneybusiness.industryCiclosporinmedicine.diseaseCalcium Channel BlockersKidney TransplantationTransplantationEndocrinologymedicine.anatomical_structurechemistryToxicityCyclosporineSurgeryCalciumEmulsionsbusinessIntracellularImmunosuppressive Agentsmedicine.drugTransplantation proceedings
researchProduct

Current Surgical Treatment Standards for Esophageal and Esophagogastric Junction Cancer

2020

A number of different surgical techniques for the treatment of cancer of the esophagus and the esophagogastric junction have been proposed. Guidelines generally recommend a transthoracic approach for esophageal cancer, including Siewert type I tumors. In tumors of the proximal esophageal third, transthoracic esophagectomy may be extended to a three-field approach, including resection of cervical lymph nodes. However, the choice between transthoracic esophagectomy with intrathoracic anastomosis (Ivor Lewis esophagectomy) and the three-incision approach with cervical esophago-gastrostomy (McKeown esophagectomy) remains controversial, with guidelines varying among different countries. Furtherm…

medicine.medical_specialtyEsophageal Neoplasms610 Medicine & healthGenetics and Molecular BiologyTransthoracic esophagectomyAdenocarcinomaGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineEsophagusHistory and Philosophy of Science1300 General Biochemistry Genetics and Molecular BiologyGastricmedicineHumansEsophagogastric junctionEsophagusNeoplasm MetastasisSurgical treatmentCancer10217 Clinic for Visceral and Transplantation Surgery1207 History and Philosophy of Scienceddc:617business.industryGeneral NeuroscienceAnastomosis SurgicalCancer2800 General NeuroscienceEsophageal cancermedicine.diseaseSurgeryEsophagectomyEsophagogastric junctionmedicine.anatomical_structureCervical lymph nodes030220 oncology & carcinogenesisGeneral BiochemistryAdenocarcinoma030211 gastroenterology & hepatologySurgeryEsophagogastric Junctionbusiness
researchProduct

Meta-analysis of Randomized Controlled Trials and Individual Patient Data Comparing Minimally Invasive With Open Oesophagectomy for Cancer

2021

Minimally invasive oesophagectomy (MIO) for oesophageal cancer may reduce surgical complications compared with open oesophagectomy. MIO is, however, technically challenging and may impair optimal oncological resection. The aim of the present study was to assess if MIO for cancer is beneficial.A systematic literature search in MEDLINE, Web of Science and CENTRAL was performed and randomized controlled trials (RCTs) comparing MIO with open oesophagectomy were included in a meta-analysis. Survival was analysed using individual patient data. Random-effects model was used for pooled estimates of perioperative effects.Among 3219 articles, six RCTs were identified including 822 patients. Three-yea…

medicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatment610 Medicine & healthLower risklaw.inventionRandomized controlled triallawOpen ResectionMedicineHumansMinimally Invasive Surgical ProceduresRandomized Controlled Trials as Topic10217 Clinic for Visceral and Transplantation Surgerybusiness.industryCancerOdds ratioPerioperativeLength of Staymedicine.diseaseSurgery2746 SurgeryEsophagectomyTreatment OutcomeEsophagectomyMeta-analysisSurgerybusiness
researchProduct

Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-Versus-Host Disease with Prednisone and Everolimus (PredEver first): A Prospective Mult…

2019

Background Chronic graft-versus-host disease (cGVHD) is the major cause of treatment related morbidity and mortality after allogeneic stem cell transplantation (allo-HSCT). Recently Paul Martin et al. reported that treatment success at 1 year (defined as a patient being in partial (PR) or complete remission (CR) of cGVHD, in ongoing remission of underlying disease and not requiring any secondary treatment for cGVHD) was the only endpoint associated with clinical benefit. Strikingly this robust endpoint was only achieved in less than 20% of patients undergoing primary treatment for cGVHD. Therefore, although most patients show initial response to first-line therapy, long-term clinically mean…

medicine.medical_specialtyEverolimusSurrogate endpointbusiness.industrymedicine.medical_treatmentImmunologyCell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseBiochemistryGastroenterologyTransplantationGraft-versus-host diseasePrednisoneInternal medicinemedicinePrednisoloneAdverse effectbusinessmedicine.drugBlood
researchProduct

A systematic review on regenerative alveolar graft materials in clinical trials

2021

Abstract Background Alveolar cleft grafting is a necessary procedure to restore bone defects. Randomized clinical trials (RCTs) are regarded as a golden standard for investigating the efficacy of treatments. Nevertheless, risk of bias (RoB) can still affect the validity of these trials. We aimed to conduct a systemic review of all control trials (CTs) using regenerative materials for alveolar cleft reconstructions to evaluate their RoB and perform a meta-analysis of new bone formation. Methods Cochrane Oral Health Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (PubMed), EMBASE AND Google Scholar were searched up to October 2020. Thereafter, th…

medicine.medical_specialtyEvidence-based medicineMEDLINElaw.inventionIliumRandomized controlled triallawmedicineAdequacy of methodHumansTissue engineeringBone regenerationAutograftsIntention-to-treat analysisbusiness.industryEvidence-based medicineSDG 10 - Reduced InequalitiesRisk of biasJadad scaleSurgeryBone regenerationClinical trialCleft PalateMeta-analysisRegenerative medicine/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalitiesSurgeryCell transplantationbusinessAlveolar bone graftingJournal of Plastic, Reconstructive and Aesthetic Surgery
researchProduct

Machine Perfusions in Liver Transplantation: The Evidence‐Based Position Paper of the Italian Society of Organ and Tissue Transplantation

2020

The use of machine perfusion (MP) in liver transplantation (LT) is spreading worldwide. However, its efficacy has not been demonstrated, and its proper clinical use has far to go to be widely implemented. The Società Italiana Trapianti d’Organo (SITO) promoted the development of an evidence-based position paper. A 3-step approach has been adopted to develop this position paper. First, SITO appointed a chair and a cochair who then assembled a working group with specific experience of MP in LT. The Guideline Development Group framed the clinical questions into a patient, intervention, control, and outcome (PICO) format, extracted and analyzed the available literature, ranked the quality of th…

medicine.medical_specialtyEvidence-based practice2747 TransplantationGRADE; donor after circulatory death; donor brain death; hypothermic machine; liver transplant; machine perfusion; normothermic machine; normothermic regional perfusion; position papermedicine.medical_treatmentDelphi methodMEDLINEhypothermic machine610 Medicine & healthdonor after circulatory deathliver perfusion machine030230 surgeryLiver transplantationnormothermic regional perfusionliver03 medical and health sciences0302 clinical medicinenormothermic machineHumansMedicineMedical physics10217 Clinic for Visceral and Transplantation SurgeryHumansItalyTransplantationMachine perfusionHepatologybusiness.industrymachine perfusionOrgan Preservationdonor brain deathperfusion machineInstitutional review boardLiver Transplantation2746 SurgeryPerfusionTransplantationliver transplantGRADEItalyPosition paper2721 Hepatology030211 gastroenterology & hepatologySurgerybusinessposition paperHumanLiver Transplantation
researchProduct